$48.86
3.47% today
Nasdaq, Apr 02, 09:21 pm CET
ISIN
US88023B1035
Symbol
TEM

Tempus AI Stock price

$47.22
-3.71 7.28% 1M
-5.85 11.02% 6M
+13.46 39.87% YTD
+10.22 27.62% 1Y
+10.22 27.62% 3Y
+10.22 27.62% 5Y
+10.22 27.62% 10Y
Nasdaq, Closing price Tue, Apr 01 2025
-1.02 2.11%
ISIN
US88023B1035
Symbol
TEM

Key metrics

Market capitalization $8.13b
Enterprise Value $8.15b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 11.76
P/S ratio (TTM) P/S ratio 11.73
P/B ratio (TTM) P/B ratio 135.88
Revenue growth (TTM) Revenue growth 30.38%
Revenue (TTM) Revenue $693.40m
EBIT (operating result TTM) EBIT $-688.38m
Free Cash Flow (TTM) Free Cash Flow $-211.17m
Cash position $448.26m
EPS (TTM) EPS $-4.75
P/E forward negative
P/S forward 6.57
EV/Sales forward 6.59
Short interest 13.28%
Show more

Is Tempus AI a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

Tempus AI Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Tempus AI forecast:

6x Buy
46%
7x Hold
54%

Analyst Opinions

13 Analysts have issued a Tempus AI forecast:

Buy
46%
Hold
54%

Financial data from Tempus AI

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
693 693
30% 30%
100%
- Direct Costs 325 325
28% 28%
47%
369 369
33% 33%
53%
- Selling and Administrative Expenses 703 703
176% 176%
101%
- Research and Development Expense 317 317
71% 71%
46%
-651 -651
300% 300%
-94%
- Depreciation and Amortization 37 37
12% 12%
5%
EBIT (Operating Income) EBIT -688 -688
251% 251%
-99%
Net Profit -706 -706
230% 230%
-102%

In millions USD.

Don't miss a Thing! We will send you all news about Tempus AI directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Tempus AI Stock News

Neutral
Business Wire
4 days ago
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the company is scheduled to exhibit 4 abstracts at the American College of Cardiology (ACC) Annual Meeting, which convenes from March 29-31 in Chicago, Illinois. This is the first year that Tempus is presenting research, all of ...
Neutral
MarketBeat
4 days ago
The American stock markets have had a rough month as investors remain jittery over international tariff fears. While this market downturn has affected most sectors of the economy, healthcare stocks are doing exceptionally well, outperforming the general market as the most successful sector of 2025 so far.
Neutral
Business Wire
7 days ago
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will present at the 24th Annual Needham Virtual Healthcare Conference on April 7-10, 2025. Tempus' Chief Financial Officer, Jim Rogers, will participate in a fireside discussion at the conference on Wednesday, April 9. A live webcast of the con...
More Tempus AI News

Company Profile

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Head office United States
CEO Eric Lefkofsky
Employees 2,400
Website www.tempus.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today